Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Cancer Research
Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
Clinical Research (Excluding Clinical Trials)

Abstract 1627: Phenotypic and functional evaluation of peripheral blood cell subsets in children at the completion of induction therapy for acute lymphoblastic leukemia

Nina Rolf, Amina Kariminia, Kinga K. Smolen, Caron Strahlendorf and Gregor S. Reid
Nina Rolf
University of British Columbia, Vancouver, British Columbia, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amina Kariminia
University of British Columbia, Vancouver, British Columbia, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kinga K. Smolen
University of British Columbia, Vancouver, British Columbia, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Caron Strahlendorf
University of British Columbia, Vancouver, British Columbia, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gregor S. Reid
University of British Columbia, Vancouver, British Columbia, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1538-7445.AM2015-1627 Published August 2015
  • Article
  • Info & Metrics
Loading
Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA

Abstract

Acute lymphoblastic leukemia (ALL) is the most common malignancy in children, accounting for more than one quarter of the new cases of pediatric cancer each year. Despite significant improvements in cure rates, recurrent ALL causes 10% of childhood cancer deaths and the need for new treatment strategies has not diminished. Although ALL has long been viewed as a poor target for immune therapy, it has recently been reported that the peripheral blood absolute lymphocyte count (ALC) at completion of induction chemotherapy is prognostic for outcome. This finding suggests that the immune environment during therapy may play a role in protecting against disease progression. It is currently unknown, however, whether ALC is simply a marker of bone marrow recovery or whether particular immune cell subsets at this early time-point confer a beneficial effect. To address this question, we have initiated a flow-cytometric study of 20 peripheral blood leukocyte populations, obtained at Day 29 from children undergoing therapy for precursor B cell ALL. The goal of this study is to correlate the size and responsiveness of the cell subsets with ALC in order to identify potential immune-mediators of the high ALC-associated favorable outcome. To date we have evaluated 8 patients for T cells (5 subsets), B cells (6 subsets), NK cells (3 subsets), NKT cells (2 subsets), dendritic cells (2 subsets), monocytes, and granulocytes. In addition to this extensive phenotypic characterization, all Day 29 blood samples have been stimulated with a panel of Toll-like receptor (TLR) ligands to evaluate functional responsiveness. Although we have not yet identified a single lymphocyte population that significantly correlates with ALC, clear trends, most notably with myeloid dendritic cells, have emerged that suggest that ALC may be indicative of specific immune activity. TLR-induced cytokine production is currently being quantified to determine whether higher ALC correlates with a specific pattern of response. While a large-scale prospective study to validate prognostic significance of ALC in children with high-risk ALL is underway, to our knowledge our ongoing study is the first to investigate the specific leukocyte composition of Day 29 peripheral blood for significant links with ALC. The identification of the mechanism(s) underlying ALC-associated outcomes may reveal novel strategies for enhanced immune-mediated control of ALL after chemotherapy.

Citation Format: Nina Rolf, Amina Kariminia, Kinga K. Smolen, Caron Strahlendorf, Gregor S. Reid. Phenotypic and functional evaluation of peripheral blood cell subsets in children at the completion of induction therapy for acute lymphoblastic leukemia. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 1627. doi:10.1158/1538-7445.AM2015-1627

  • ©2015 American Association for Cancer Research.
Previous
Back to top
Cancer Research: 75 (15 Supplement)
August 2015
Volume 75, Issue 15 Supplement
  • Table of Contents
  • Index by Author

Sign up for alerts

Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Abstract 1627: Phenotypic and functional evaluation of peripheral blood cell subsets in children at the completion of induction therapy for acute lymphoblastic leukemia
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
Citation Tools
Abstract 1627: Phenotypic and functional evaluation of peripheral blood cell subsets in children at the completion of induction therapy for acute lymphoblastic leukemia
Nina Rolf, Amina Kariminia, Kinga K. Smolen, Caron Strahlendorf and Gregor S. Reid
Cancer Res August 1 2015 (75) (15 Supplement) 1627; DOI: 10.1158/1538-7445.AM2015-1627

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Abstract 1627: Phenotypic and functional evaluation of peripheral blood cell subsets in children at the completion of induction therapy for acute lymphoblastic leukemia
Nina Rolf, Amina Kariminia, Kinga K. Smolen, Caron Strahlendorf and Gregor S. Reid
Cancer Res August 1 2015 (75) (15 Supplement) 1627; DOI: 10.1158/1538-7445.AM2015-1627
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
Advertisement

Related Articles

Cited By...

More in this TOC Section

Clinical Research (Excluding Clinical Trials)

  • Abstract LB-240: Circulating tumor cell (CTC) analysis in NRG oncology/RTOG 1014, repeat breast conserving treatment after in-breast recurrence (IBR)
  • Abstract LB-241: Quantification of EGFR allele frequency predicts tumor response to EGFR tyrosine kinase inhibitors
  • Abstract LB-238: Dissecting primary resistance to anti-EGFR monoclonal antibodies (anti-EGFRs) in RAS and BRAF wild-type (wt) metastatic colorectal cancer (mCRC)
Show more 3

Poster Presentations - Proffered Abstracts

  • Abstract LB-240: Circulating tumor cell (CTC) analysis in NRG oncology/RTOG 1014, repeat breast conserving treatment after in-breast recurrence (IBR)
  • Abstract LB-241: Quantification of EGFR allele frequency predicts tumor response to EGFR tyrosine kinase inhibitors
  • Abstract LB-238: Dissecting primary resistance to anti-EGFR monoclonal antibodies (anti-EGFRs) in RAS and BRAF wild-type (wt) metastatic colorectal cancer (mCRC)
Show more 3

Poster Presentations - Pediatric Cancer: Clinical Investigations / Regulatory Science and Policy

  • Abstract 1636: A model-based approach toward clinical pipeline optimization
  • Abstract 1633: Calorie and fat restriction during chemotherapy improves survival in obese mice with syngeneic acute lymphoblastic leukemia
Show more 3
  • Home
  • Alerts
  • Feedback
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2018 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement